Trial Profile
Phase I dose-escalation study of oral administration of S 78454 given with tamoxifen 20 mg in the treatment of patients with advanced breast cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Dec 2015
Price :
$35
*
At a glance
- Drugs Abexinostat (Primary) ; Tamoxifen
- Indications Adenocarcinoma; Advanced breast cancer
- Focus Adverse reactions
- Sponsors IRIS
- 17 Dec 2015 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 05 Feb 2014 New trial record